Document Detail

Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction.
MedLine Citation:
PMID:  20890426     Owner:  NLM     Status:  MEDLINE    
We sought to determine the prevalence of metabolic syndrome (MS) in patients with acute myocardial infarction and its effect on clinical outcomes. Employing data from the Korea Acute Myocardial Infarction Registry, a total of 1,990 patients suffered from acute ST-elevation myocardial infarction (STEMI) between November 2005 and December 2006 were categorized according to the National Cholesterol Education Program-Adult Treatment Panel III criteria of MS. Primary study outcomes included major adverse cardiac events (MACE) during one-year follow-up. Patients were grouped based on existence of MS: group I: MS (n=1,182, 777 men, 62.8±12.3 yr); group II: Non-MS (n=808, 675 men, 64.2±13.1 yr). Group I showed lower left ventricular ejection fraction (LVEF) (P=0.005). There were no differences between two groups in the coronary angiographic findings except for multivessel involvement (P=0.01). The incidence of in-hospital death was higher in group I than in group II (P=0.047), but the rates of composite MACE during one-year clinical follow-up showed no significant differences. Multivariate analysis showed that low LVEF, old age, MS, low high density lipoprotein cholesterol and multivessel involvement were associated with high in-hospital death rate. In conclusion, MS is an important predictor for in-hospital death in patients with STEMI.
Min Goo Lee; Myung Ho Jeong; Youngkeun Ahn; Shung Chull Chae; Seung Ho Hur; Taek Jong Hong; Young Jo Kim; In Whan Seong; Jei Keon Chae; Jay Young Rhew; In Ho Chae; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Chong Jin Kim; Donghoon Choi; Yang Soo Jang; Junghan Yoon; Wook Sung Chung; Jeong Gwan Cho; Ki Bae Seung; Seung Jung Park
Related Documents :
11759936 - Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their...
8801446 - The effect of pravastatin on coronary events after myocardial infarction in patients wi...
220486 - The evidence for the antiatherogenicity of high density lipoprotein in man.
1756026 - Recent evidence for the involvement of catecholamines and of macrophages in atheroscler...
9060886 - Medical management of selected patients with left ventricular free wall rupture during ...
16995456 - Esophageal perforation--associated risk with balloon tamponade after endoscopic therapy...
Publication Detail:
Type:  Journal Article     Date:  2010-09-17
Journal Detail:
Title:  Journal of Korean medical science     Volume:  25     ISSN:  1598-6357     ISO Abbreviation:  J. Korean Med. Sci.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-04     Completed Date:  2011-02-17     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  8703518     Medline TA:  J Korean Med Sci     Country:  Korea (South)    
Other Details:
Languages:  eng     Pagination:  1456-61     Citation Subset:  IM    
The Heart Center of Chonnam National University Hospital, Gwangju, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Age Factors
C-Reactive Protein / analysis
Cholesterol, LDL / blood
Coronary Angiography
Metabolic Syndrome X / complications*,  epidemiology
Middle Aged
Multivariate Analysis
Myocardial Infarction / complications*,  mortality,  therapy
Predictive Value of Tests
Treatment Outcome
Ventricular Dysfunction, Left / complications,  physiopathology
Reg. No./Substance:
0/Cholesterol, LDL; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.
Next Document:  Long-term prognosis of left ventricular lead.